BioAge Labs (BIOA) Other Non-Current Liabilities (2023 - 2026)

BioAge Labs (BIOA) has 4 years of Other Non-Current Liabilities data on file, last reported at $477000.0 in Q1 2026.

• For the quarter ending Q1 2026, Other Non-Current Liabilities rose 391.75% year-over-year to $477000.0; the trailing twelve-month figure through Mar 2026 stood at $477000.0 (up 391.75% YoY), and the FY2025 full-year result was $370000.0, up 137.18% from the prior year.
• Other Non-Current Liabilities grew to $477000.0 in Q1 2026, from $370000.0 in the prior quarter.
• In the past five years, Other Non-Current Liabilities ranged from a high of $613000.0 in Q3 2024 to a low of $97000.0 in Q1 2025.
• A 4-year average of $275000.0 and a median of $192500.0 in 2023 frame the typical range for Other Non-Current Liabilities.
• Across the five-year window, Other Non-Current Liabilities slumped 75.53% in 2025 and surged 391.75% in 2026, its largest moves.
• Tracing BIOA's Other Non-Current Liabilities over 4 years: stood at $229000.0 in 2023, then tumbled by 31.88% to $156000.0 in 2024, then surged by 137.18% to $370000.0 in 2025, then climbed by 28.92% to $477000.0 in 2026.
• Business Quant data shows BIOA's Other Non-Current Liabilities at $477000.0 in Q1 2026, $370000.0 in Q4 2025, and $150000.0 in Q3 2025.